Mutual augmentation of the induction of the histamine-forming enzyme, histidine decarboxylase, between alendronate and immuno-stimulants (IL-1, TNF, and LPS), and its prevention by clodronate

被引:40
作者
Deng, Xue
Yu, Zhiqian
Funayama, Hiromi
Shoji, Noriaki
Sasano, Takashi
Iwakura, Yoichiro
Sugawara, Shunji
Endo, Yasuo
机构
[1] Tohoku Univ, Grad Sch Dent, Dept Mol Regulat, Aoba Ku, Sendai, Miyagi 9808575, Japan
[2] Tohoku Univ, Grad Sch Dent, Dept Oral Diag, Aoba Ku, Sendai, Miyagi 9808575, Japan
[3] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Minato Ku, Tokyo 1088639, Japan
关键词
bisphosphonates; histidine decarboxylase; lipopolysaccharide (LPS); interleukin-1 (IL-1); clodronate; alendronate;
D O I
10.1016/j.taap.2005.09.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nitrogen-containing bisphosphonates (N-BPs), powerful anti-bone-resorptive drugs, have inflammatory side effects, while histamine is not only an inflammatory mediator, but also an immuno-modifier. In murine models, a single intraperitoneal injection of an N-BP induces various inflammatory reactions, including the induction of the histamine-forming enzyme histidine decarboxylase (HDC) in tissues important in immune responses (such as liver, lungs, spleen, and bone marrow). Lipopolysaccharide (LPS) and the proinflammatory cytokines IL-1 and TNF are also capable of inducing HDC. We reported previously that in mice, (i) the inflammatory actions of N-BPs depend on IL-1, (ii) N-BP pretreatment augments both LPS-stimulated IL-1 production and HDC induction, and (iii) the co-administration of clodronate (a non-N-BP) with an N-BP inhibits the latter's inflammatory actions (including HDC induction). Here, we add the new findings that (a) pretreatment with alendronate (a typical N-BP) augments both IL-1- and TNF-induced HDC elevations, (b) LPS pretreatment augments the alendronate-induced HDC elevation, (c) co-administration of clodronate with alendronate abolishes these augmentations, (d) alendronate does not induce HDC in IL-1-deficient mice even if they are pretreated with LPS, and (e) alendronate increases IL-1 p in all tissues tested, but not in the serum. These results suggest that (1) there are mutual augmentations between alendronate and immuno-stimulants (IL-1, TNF, and LPS) in HDC induction, (2) tissue IL-10 is important in alendronate-stimulated HDC induction, and (3) combination use of clodronate may have the potential to reduce the inflammatory effects of alendronate (we previously found that clodronate, conveniently, does not inhibit the anti-bone-resorptive activity of alendronate). (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:64 / 73
页数:10
相关论文
共 65 条
  • [1] THE ACUTE-PHASE RESPONSE AFTER BISPHOSPHONATE ADMINISTRATION
    ADAMI, S
    BHALLA, AK
    DORIZZI, R
    MONTESANTI, F
    ROSINI, S
    SALVAGNO, G
    LOCASCIO, V
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1987, 41 (06) : 326 - 331
  • [2] Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol
    Adami, S
    Braga, V
    Guidi, G
    Gatti, D
    Gerardi, D
    Fracassi, E
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (03) : 599 - 604
  • [3] Toll-like receptor signaling
    Akira, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) : 38105 - 38108
  • [4] AMIN D, 1992, J LIPID RES, V33, P1657
  • [5] AMIN D, 1996, DRUG RES, V46, P759
  • [6] Sensitization associated with stressors and cytokine treatments
    Anisman, H
    Merali, Z
    Hayley, S
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2003, 17 (02) : 86 - 93
  • [7] Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases
    Bagan, JV
    Murillo, J
    Jimenez, Y
    Poveda, R
    Milian, MA
    Sanchis, JM
    Silvestre, FJ
    Scully, C
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (02) : 120 - 123
  • [8] THE BIOLOGY OF CACHECTIN/TNF - A PRIMARY MEDIATOR OF THE HOST RESPONSE
    BEUTLER, B
    CERAMI, A
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1989, 7 : 625 - 655
  • [9] Long-term analgesic effect of clodronate in rodents
    Bonabello, A
    Galmozzi, MR
    Canaparo, R
    Serpe, L
    Zara, GP
    [J]. BONE, 2003, 33 (04) : 567 - 574
  • [10] Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules
    Chesnokova, V
    Chesnokova, V
    [J]. ENDOCRINOLOGY, 2002, 143 (05) : 1571 - 1574